Form 4: MAXIMUS Executive Granted 7,409 Restricted Stock Units

MAXIMUS General Manager Ilene Baylinson received a grant of 7,409 restricted stock units, vesting over three years.

Summary

• Ilene R. Baylinson, General Manager Health & Human at MAXIMUS, INC. (MMS), was granted 7,409 shares of common stock.
• The transaction occurred on November 24, 2025, and was reported on November 25, 2025.
• The grant represents Restricted Stock Units (RSUs) with a transaction price of $0 per share, indicating an equity award.
• These RSUs will vest ratably over a three-year period on September 30, 2026, September 30, 2027, and September 30, 2028.
• Each RSU provides a contingent right to receive one share of MAXIMUS common stock.
• Following this transaction, Ilene R. Baylinson beneficially owns 21,549.135 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is positive for the executive receiving the grant, as it represents a significant equity award. For the company, it's a neutral to slightly positive event, reflecting standard executive compensation practices aimed at aligning interests and retaining talent, with minimal immediate impact on fundamentals.

Positives

• The grant of 7,409 Restricted Stock Units (RSUs) aligns the executive's interests with those of shareholders, incentivizing long-term performance.
• Equity compensation at a $0 price indicates a direct award, which is a common and attractive form of executive remuneration.

Future Outlook

The granted Restricted Stock Units are scheduled to vest ratably over three years, with specific vesting dates in September 2026, 2027, and 2028, subject to the terms of the award and potential deferred vesting.

Industry Context

The grant of Restricted Stock Units is a standard practice in executive compensation across various industries, including government services and technology, aiming to retain key talent and align management incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice, comparable to compensation structures at companies like Accenture, Booz Allen Hamilton, and Leidos, which also utilize equity awards to incentivize performance and retention.
• A three-year ratable vesting schedule is typical for such grants, providing a balance between immediate incentive and long-term commitment, consistent with industry benchmarks for executive equity awards.

Stakeholder Impact

• Shareholders: Potential minor dilution over time as RSUs vest into common stock, but the grant aims to align executive performance with shareholder value.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives.

Next Steps

• The Restricted Stock Units will vest in three equal annual installments on September 30, 2026, September 30, 2027, and September 30, 2028.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a company executive as part of their compensation. It does not contain information that would fundamentally alter the company's financial outlook, operational performance, or competitive position. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is appropriate based solely on this filing.

Keywords

MAXIMUS, MMS, Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Equity Grant